-
Amarin Rallies After Diabetes Association Adds Fish Oil Capsule To Standards of Care List
Thursday, March 28, 2019 - 10:50am | 406Read More...Amarin Corporation plc (NASDAQ: AMRN) shares have been on a strong upward trend since late Wednesday, with the buying momentum continuing into Thursday's session. What Happened Amarin's stock was reacting to a release from the American Diabetes Association, or ADA, that includes Amarin...
-
Lesson Learned: Don't Trust Twitter Users With A Multi-Billion-Dollar Secret
Wednesday, June 15, 2016 - 10:46am | 324Read More...Novo Nordisk A/S (ADR) (NYSE: NVO) presented data at the American Diabetes Association on Monday and trusted the doctors in attendance to not share the confidential and market-moving data they just saw. As if that would actually happen in the modern day of smartphones and social media....
-
JMP Sees A 'Negative Market Tone' In Biotechnology
Monday, June 15, 2015 - 1:31pm | 482Read More...In a new report, analysts at JMP Securities focused on stocks and recent developments in the world of biotechnology. Overall, much of the sector has been under pressure recently from a negative market tone and “puzzling” Endocrinology and Metabolic Drug Advisory Committee (EMDAC)...
-
Bank Of America On Merck: 'MAGNIF-TECOS!'
Tuesday, April 28, 2015 - 9:30am | 327Read More...In a report published Tuesday, Bank of America analyst Colin Bristow commented on Merck & Co., Inc. (NYSE: MRK)'s announcement of top-line results for the TECOS trial, noting that the study met its primary endpoint of non-inferiority versus placebo for the composite CV endpoint. The...
-
3 Companies Helping To Keep Diabetes Rates Lower
Wednesday, October 1, 2014 - 2:39pm | 728Read More...There has been some good news recently regarding diabetes, according to the Centers for Disease Control and Prevention. A new study published in the Journal of the American Medical Association indicated that after almost two decades of increase, the rate of diabetes in the United States may be...
-
5 New Medical Technologies For Diabetics
Friday, July 18, 2014 - 1:10pm | 788Read More...News of the recent partnership between European drugmaker Novartis (NYSE: NVS) and Google (NASDAQ: GOOG) (NASDAQ: GOOGL) to develop a contact lens designed to monitor blood sugar levels in diabetics has drawn attention to several other new diabetes treatment developments. Information Week...
-
Novartis Joins Google To Develop Contacts For Diabetics
Friday, July 18, 2014 - 9:59am | 606Read More...Development of devices and mobile applications in the health care sector has exploded of late. Now, according to The New York Times, drugmaker Novartis (NYSE: NVS) is collaborating with Google (NASDAQ: GOOG) (NASDAQ: GOOGL) to develop a smart contact lens that would constantly monitor the blood...
-
Investing for the Diabetes Epidemic (DVA, FMS, WST, BDX, RVP)
Monday, April 11, 2011 - 6:35pm | 224Read More...Sometimes we can find opportunities in sobering statistics. On a global scale, diabetes is reaching epidemic proportions with an estimated 285 million suffers worldwide. In America, nearly 24 million people are currently diagnosed and that number is expected to grow by an additional 12 million by...
-
Amylin Pharmaceuticals Announces Online Summit (AMLN)
Monday, June 7, 2010 - 4:21pm | 305Read More...Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is hosting an online summit focusing on perspectives within the diabetes community and information from topics that will be discussed at the American Diabetes Association's (ADA's) upcoming 70th Annual Scientific Sessions in...
